Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:20   Issue: 6
Pp: 391-391
M.P. Carty
DOI: 10.2174/156800962006200707220550
Published on: 07 July, 2020



Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer

Volume:20   Issue: 6
Pp: 392-409
Sagar O. Rohondia*, Zainab Sabry Othman Ahmed and Q. Ping Dou*
DOI: 10.2174/1568009620666200226094000
Published on: 07 July, 2020




COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide

Volume:20   Issue: 6
Pp: 410-416
Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li*, Yong Cai* and Hui Wang*
DOI: 10.2174/1568009620666200414151419
Published on: 07 July, 2020




The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers: Rational Strategies and Recent Progress

Volume:20   Issue: 6
Pp: 417-428
Sadaf Ghanaatgar-Kasbi, Majid Khazaei, Azam Rastgar-Moghadam, Gordon A. Ferns, Seyed Mahdi Hassanian and Amir Avan*
DOI: 10.2174/1568009620666200424144303
Published on: 07 July, 2020




Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy

Volume:20   Issue: 6
Pp: 429-460
Mohammed Shaaban, Heba Othman, Takwa Ibrahim, Mariam Ali, Mohamed Abdelmoaty, Abdel-Rahman Abdel-Kawi, Ahmed Mostafa, Aya El Nakeeb, Heba Emam and Alaa Refaat*
DOI: 10.2174/1568009620666200422081912
Published on: 07 July, 2020




CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis

Volume:20   Issue: 6
Pp: 461-470
Jijian Sun*, Shijie Pan, Hongquan Cui and Hao Li
DOI: 10.2174/1568009620666200409130032
Published on: 07 July, 2020